Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Site-specific Trigger Point Dry Needling Evoke Segmental Neuromodulation in the Lower Extremity and if so, do These Changes Make an Impact on the Subject's Disability?

NCT02838394 is registered in ClinicalTrials.gov with Brigham Young University as lead sponsor.

NCT NCT02838394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02838394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Site-specific Trigger Point Dry Needling Evoke Segmental Neuromodulation in the Lower Extremity and if so, do These Changes Make an Impact on the Subject's Disability?
Lead sponsor
Brigham Young University
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2016
Completion date
August 31, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pain syndrome, myofascial trigger point pain